1. Home
  2. RENB vs RDZN Comparison

RENB vs RDZN Comparison

Compare RENB & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RENB
  • RDZN
  • Stock Information
  • Founded
  • RENB 2011
  • RDZN 2015
  • Country
  • RENB United States
  • RDZN United States
  • Employees
  • RENB N/A
  • RDZN N/A
  • Industry
  • RENB Biotechnology: Pharmaceutical Preparations
  • RDZN Blank Checks
  • Sector
  • RENB Health Care
  • RDZN Finance
  • Exchange
  • RENB Nasdaq
  • RDZN Nasdaq
  • Market Cap
  • RENB 121.3M
  • RDZN 107.6M
  • IPO Year
  • RENB N/A
  • RDZN N/A
  • Fundamental
  • Price
  • RENB $0.71
  • RDZN $1.72
  • Analyst Decision
  • RENB
  • RDZN Strong Buy
  • Analyst Count
  • RENB 0
  • RDZN 2
  • Target Price
  • RENB N/A
  • RDZN $5.00
  • AVG Volume (30 Days)
  • RENB 1.8M
  • RDZN 850.9K
  • Earning Date
  • RENB 02-12-2025
  • RDZN 02-10-2025
  • Dividend Yield
  • RENB N/A
  • RDZN N/A
  • EPS Growth
  • RENB N/A
  • RDZN N/A
  • EPS
  • RENB N/A
  • RDZN N/A
  • Revenue
  • RENB N/A
  • RDZN $46,448,411.00
  • Revenue This Year
  • RENB N/A
  • RDZN $4.38
  • Revenue Next Year
  • RENB N/A
  • RDZN $61.53
  • P/E Ratio
  • RENB N/A
  • RDZN N/A
  • Revenue Growth
  • RENB N/A
  • RDZN 57.97
  • 52 Week Low
  • RENB $0.40
  • RDZN $0.71
  • 52 Week High
  • RENB $5.25
  • RDZN $7.17
  • Technical
  • Relative Strength Index (RSI)
  • RENB 39.34
  • RDZN 48.45
  • Support Level
  • RENB $0.70
  • RDZN $1.41
  • Resistance Level
  • RENB $0.94
  • RDZN $1.62
  • Average True Range (ATR)
  • RENB 0.14
  • RDZN 0.32
  • MACD
  • RENB -0.03
  • RDZN -0.09
  • Stochastic Oscillator
  • RENB 2.57
  • RDZN 23.95

About RENB Renovaro Biosciences Inc.

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

About RDZN Roadzen Inc.

Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.

Share on Social Networks: